BURLINGAME, Calif. (AP) — BURLINGAME, Calif. (AP) — Corvus Pharmaceuticals Inc. (CRVS) on Monday reported a loss of $7.9 million in its first quarter.
The Burlingame, California-based company said it had a loss of 17 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRVS at https://www.zacks.com/ap/CRVS
There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.
Donald Trump’s aides have drawn up secret plans to oust the chairman of the Federal Reserve and allow the president to set interest rates, according to reports.
These proven wealth builders could be exactly what you're searching for right now.
The property report includes 85 major metropolitan areas in the U.S. with populations of at least 750,000.
Walmart's CEO went from earning $6.50 an hour to $25 million a year—here are his three tips for climbing the corporate ladder like him
The JPMorgan Nasdaq Equity Premium Income ETF offers a compelling blend of income and upside to my portfolio.
Here's what could happen next to Microsoft shares.
Jamie Dimon and Jerome Powell are taking the European viewpoint on soaring debt levels in the U.S.
(Bloomberg) -- Ukraine sustained a heavy Russian missile barrage overnight aimed at gas infrastructure and other targets, while striking back a Russian oil refinery with drones. Most Read from BloombergPlunging Home Prices, Fleeing Companies: Austin’s Glow Is FadingApple Intensifies Talks With OpenAI for iPhone Generative AI FeaturesWall Street Humbled as Fast-Reversing Markets Confound the ProsThe Long, Slow Death of Urban NightlifeJavier Milei Fuels Wild Rally That Makes Peso No. 1 in WorldMos
It's been an "everything buy bonds" bull rally in markets for months, but BofA is cautiously watching a couple of indicators.